Physician profile
Jay A Brown
NPI 1538167143
$1,067.52
in general payments reported to CMS, 2019-2025
17 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $31.02 · 2021: $188 · 2022: $156 · 2023: $31.00 · 2024: $251 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.61 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $204.85 | 2019-2022 | |
| Oculus Surgical INC. | $165.75 | 2024 | |
| Alcon Vision LLC | $123.26 | 2021-2025 | Luxor |
| Sight Sciences, INC. | $100.01 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $93.00 | 2022-2023 | Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $87.12 | 2020-2021 | |
| Dompe US, INC. | $54.06 | 2025 | Oxervate |
| Glaukos Corporation | $43.06 | 2022 | |
| Abbvie INC. | $34.19 | 2025 | |
| Aerie Pharmaceuticals, INC. | $32.07 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $29.17 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $24.78 | 2019 | |
| Amgen INC. | $16.67 | 2024 | |
| Beaver-Visitec International, INC. | $15.90 | 2019 | |
| Ocular Therapeutix, INC. | $15.80 | 2024 | Dextenza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.67 | 2019 | |
| Coherus Oncology, INC. | $13.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.